Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

Revvity Inc at Raymond James Institutional Investors Conference Transcript

Mar 05, 2024 / 02:15PM GMT
Release Date Price: R$19.54
Andrew Harris Cooper
Raymond James & Associates, Inc., Research Division - Research Analyst

Good morning, everyone. I'm Andrew Cooper, the Life Science Tools and Diagnostics analyst here at Raymond James. Happy to be joined by the team from Revvity. We're going to do a little bit of presentation and then have some fireside chat as well. So with that, I'm going to pass it right over to Max, Chief Financial Officer and take it away.

Maxwell Krakowiak
Revvity, Inc. - Senior VP & CFO

Thanks, Andrew. And I appreciate you having us here. And for those of us that haven't followed Revvity as closely over the past year, there's been a ton of change that has happened. And so hopefully, today, we'll spend the next 10 minutes kind of giving you a high-level overview of that transformation and why we're so excited about the future of our company. I'd encourage you to read our safe harbor statement. You can also find additional disclosures on our website for any forward-looking statements that we'll make for today.

So a question of what is Revvity? So I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot